MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 30, 2006
Brian Gorman
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 28, 2004
Brian Gorman
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K. mark for My Articles similar articles
The Motley Fool
November 7, 2007
Billy Fisher
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. mark for My Articles similar articles
The Motley Fool
October 26, 2005
Stephen D. Simpson
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. mark for My Articles similar articles
The Motley Fool
June 28, 2005
Brian Gorman
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news. mark for My Articles similar articles
The Motley Fool
December 10, 2004
Brian Gorman
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction. mark for My Articles similar articles
The Motley Fool
April 7, 2011
Brandon Glenn
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors. mark for My Articles similar articles
The Motley Fool
May 2, 2005
Brian Gorman
Cardinal Health Perks Up The drug distribution company is working through its problems, which should make for a brighter fiscal 2006. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 24, 2011
Brandon Glenn
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? mark for My Articles similar articles
The Motley Fool
August 3, 2006
Ryan Fuhrmann
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. mark for My Articles similar articles
The Motley Fool
August 5, 2005
Stephen D. Simpson
Can This Cardinal Sing? If Cardinal Health succeeds in its plans to return more capital to shareholders, this could become an interesting income play. This stock is worth keeping an eye on for the future. mark for My Articles similar articles
BusinessWeek
November 24, 2003
Roger O. Crockett
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas. mark for My Articles similar articles
The Motley Fool
July 1, 2004
W.D. Crotty
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. mark for My Articles similar articles
The Motley Fool
September 30, 2008
Brian Orelli
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business? mark for My Articles similar articles
The Motley Fool
January 2, 2004
Alyce Lomax
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. mark for My Articles similar articles
The Motley Fool
January 18, 2005
Brian Gorman
Cardinal Doesn't Get Ruffled The drug distributor's potential loss of Japanese pharmaceutical Eisai will hurt in the short term, but fortunately for investors Cardinal Health continues to plan wisely. mark for My Articles similar articles
The Motley Fool
January 25, 2007
Brian Lawler
Johnson & Johnson's Earnings Glee Johnson & Johnson keeps growing, even if the pharmaceutical segment is a bit sluggish. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 20, 2004
Tom Taulli
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth. mark for My Articles similar articles
InternetNews
July 18, 2006
Michael Hickins
Microsoft Aligns Financials Microsoft hopes its strategy elicits a better reception from financial analysts than it did in April. mark for My Articles similar articles
The Motley Fool
November 15, 2006
La-Z-Boy Lagging Less: Fool by Numbers The furniture maker released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
May 6, 2008
Steven Renaldi
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. mark for My Articles similar articles
The Motley Fool
May 2, 2008
Steven Renaldi
Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it. mark for My Articles similar articles
The Motley Fool
September 2, 2009
Brian Orelli
Should You Buy This Spinoff? Cardinal Health kicks its baby out of the nest. mark for My Articles similar articles
The Motley Fool
July 18, 2007
Yahoo!'s Mixed Bag of Tricks: Fool by Numbers The Internet giant released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
June 13, 2006
Ryan Fuhrmann
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. mark for My Articles similar articles
The Motley Fool
January 21, 2005
Rich Duprey
Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all. mark for My Articles similar articles
The Motley Fool
January 18, 2007
Rich Duprey
Parker Hannifin's in Control: Fool by Numbers The motion control systems manufacturer released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
July 28, 2004
Brian Gorman
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge. mark for My Articles similar articles
The Motley Fool
May 9, 2007
Tyco's "Eh" Quarter: Fool by Numbers The conglomerate released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
July 19, 2007
Not Bad, IBM: Fool by Numbers The company released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
October 8, 2007
Billy Fisher
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 27, 2006
Jim Mueller
IHOP Slips: Fool by Numbers The pancake house released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
October 18, 2005
Nathan Slaughter
Good Teamwork at J&J The health-care giant tops third-quarter estimates on strong sales of medical devices. mark for My Articles similar articles
The Motley Fool
November 8, 2011
Brandon Glenn
Cardinal Health Looks to Build China Business, but Has Long Way to Go For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity. mark for My Articles similar articles
The Motley Fool
December 1, 2006
Del Monte Dishes Duds: Fool by Numbers The food processor released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
November 9, 2006
Steady Sales at STERIS: Fool by Numbers The sterilization products maker released second-2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
April 5, 2007
Healthways Buys and Boosts: Fool by Numbers The healthcare company released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
October 26, 2006
Microchip's Ahoy: Fool by Numbers Microchip Technology released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
July 20, 2007
Motorola's Malaise: Fool by Numbers The news is all mediocre at Motorola, with no easily apparent solution. mark for My Articles similar articles
The Motley Fool
March 26, 2007
Ryan Fuhrmann
A Healthy Shade of Walgreen: Fool by Numbers The drugstore chain released second-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
July 20, 2007
Stryker's Foolishly Important Free Cash Flow Grows: Fool by Numbers The medical equipment maker released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 22, 2007
The Honeymoon Is Over for Zale: Fool by Numbers The jewelry retailer released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
March 23, 2011
Jordan DiPietro
Should You Buy and Hold Cardinal Health? Does this company have the traits of a good retirement stock? mark for My Articles similar articles
The Motley Fool
January 27, 2006
Michael Olsen
Microsoft Back on the Horse in Q2: Fool by Numbers The software giant released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 5, 2007
Ryan Fuhrmann
Global Payments Transacts Q2: Fool by Numbers The transaction processor and money-transfer firm released fiscal 2007 second-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
April 5, 2007
Emil Lee
MSC Industrial Shrugs Off Slowdown: Fool by Numbers The industrial company released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
August 9, 2006
Seth Jayson
Blackboard Chalks Up a Loss: Fool by Numbers The educational software provider released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
July 25, 2011
West Pharmaceutical Services Earnings Preview West Pharmaceutical Services will unveil its latest earnings on Thursday, July 28. mark for My Articles similar articles
The Motley Fool
March 9, 2007
Cantel Can Do It: Fool by Numbers Cantel Medical released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
August 13, 2007
Tom Taulli
Limelight Burns Out The hot tech company blows a fuse as rivals gain momentum. Given the sudden destruction of Limelight's stock, it'll probably take some time for investors to warm up to the company again. mark for My Articles similar articles